The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with ...
Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?